pune, India -- (SBWIRE) -- 03/26/2020 -- Vaccine adjuvants market is registering a healthy CAGR of 11.22% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to the various strategic developmental moves adopted by companies such as agreements, acquisitions, and collaborations and surging government expenditure on healthcare is contributing to the growth of the market. Few of the major market competitors currently working in the global vaccine adjuvants market are InvivoGen, SPI Pharma, CSL Limited, Croda International Plc, Phibro Animal Health Corporation, Avanti Polar Lipids, SEPPIC, Agenus Inc., Novavax, OZ Biosciences, Kineta Inc., Adjuvatis, Merck KGaA, GlaxoSmithKline plc, vaxine, CureVac, Astellas Pharma Inc., AstraZeneca, Bavarian Nordic, ABF Ingredients, 3M, Life Technologies (India) Pvt. Ltd and Pfizer Inc. among others
Get Sample Report + All Related Graphs & Charts @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-vaccine-adjuvants-market
Global Vaccine Adjuvants Market By Product Type (Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants, Liposome Adjuvants, Carbohydrate Adjuvants, Alum, Others), Route of Administration (Intramuscular Route, Subcutaneous Route, Intranasal Route, Oral Route, Intradermal Route, Others), Disease Type (Infectious Diseases, Cancer, Others), Application (Research Application, Commercial Application), Application Category (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), End User (Pediatric, Adults), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
With the technological advancements and innovations in the medical field, the innovative product is made which can make the diagnosis and treatment effective. There is a rise in demand for vaccines globally due to various factors such as growth in the diseases rate as well as a surge in the elderly & obese population. An adjuvant is a product which is used with the vaccines to generate a strong response and to ensure that it provides protection against infection. It has become an important for most of the clinical vaccines given globally. The most commonly used adjuvant is Aluminum hydroxide and paraffin oil. It also minimizes the amount of injected foreign material. It has broad applications in researches as well as commercial uses.
Key Developments in the Market:
- In January 2019, Croda International Plc had acquired Brenntag Biosector. This acquisition will expand the product portfolio by access to well-known brands Alhydrogel and Adju-Phos, as well as their technical and superior advanced saponin-based adjuvant systems. The Croda will integrate its sales network and distribution to accelerate the growth of Biosector. This deal will support the customers and by offering them a range of better vaccine adjuvants.
- In March 2019, Elicio Therapeutics had launched Novel Vaccine & Immunotherapy Platform to treat an array of cancers. These programs are followed by a broad preclinical pipeline of adjuvants, cellular therapy vaccines and immune stimulatory therapeutics. This launch will enable the company to expand its offering and broaden its customer base.
- The adjuvants in vaccines usage have surges which has boosted the market growth
- The prevalence of zoonotic diseases and infections is very high which propels the market growth
- The surge in livestock and high instances of diseases has driven the market growth
- The technological advances and innovations in the aluminum hydroxide based adjuvants has fueled the market growth
- The rising elderly and obese population has driven the market growth
- The adjuvant research involves huge cost which hinders the market growth
- The stringent regulator compliances and time consuming approvals had hampered the market growth
Grab Your Report at an Impressive 30% Discount! Please click Here@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-vaccine-adjuvants-market
Segmentation: Global Vaccine Adjuvants Market
By Product Type
- Particulate Adjuvants
- Adjuvant Emulsions
- Pathogen Components
- Combination Adjuvants
- Liposome Adjuvants
- Carbohydrate Adjuvants
By Route Of Administration
- Intramuscular Route
- Subcutaneous Route
- Intranasal Route
- Oral Route
- Intradermal Route
By Disease Type
- Infectious Diseases
- Research Application
- Commercial Application
By Application Category
- Human Vaccine Adjuvants
- Veterinary Vaccine Adjuvants
By End User
The global vaccine adjuvants market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of vaccine adjuvants market for global, Europe, North America, Asia Pacific and South America.
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research